Drug Shortage Report for TARO-GLICLAZIDE MR
| Report ID | 169507 |
| Drug Identification Number | 02439328 |
| Brand name | TARO-GLICLAZIDE MR |
| Common or Proper name | GLICLAZIDE |
| Company Name | SUN PHARMA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GLICLAZIDE |
| Strength(s) | 60MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | A10BB |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-12-07 |
| Estimated end date | 2025-03-28 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-03-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v50 | 2025-03-17 | French | Compare |
| v49 | 2025-03-17 | English | Compare |
| v48 | 2025-03-03 | French | Compare |
| v47 | 2025-03-03 | English | Compare |
| v46 | 2025-01-28 | French | Compare |
| v45 | 2025-01-28 | English | Compare |
| v44 | 2024-11-11 | French | Compare |
| v43 | 2024-11-11 | English | Compare |
| v42 | 2024-09-09 | French | Compare |
| v41 | 2024-09-09 | English | Compare |
| v40 | 2024-06-14 | French | Compare |
| v39 | 2024-06-14 | English | Compare |
| v38 | 2024-05-07 | French | Compare |
| v37 | 2024-05-07 | English | Compare |
| v36 | 2024-03-13 | French | Compare |
| v35 | 2024-03-13 | English | Compare |
| v34 | 2024-03-01 | French | Compare |
| v33 | 2024-03-01 | English | Compare |
| v32 | 2024-01-05 | French | Compare |
| v31 | 2024-01-05 | English | Compare |